Preventing the return of smallpox: molecular modeling studies on thymidylate kinase from Variola virus.

Ana Paula Guimarães, Teodorico Castro Ramalho, Tanos Celmar Costa França

Journal: Journal of biomolecular structure & dynamics 2015;32(10):1601-12

PMID: 23998201

Free Full Text on PubMed Central View on PubMed

Abstract

Smallpox was one of the most devastating diseases in the human history and still represents a serious menace today due to its potential use by bioterrorists. Considering this threat and the non-existence of effective chemotherapy, we propose the enzyme thymidylate kinase from Variola virus (VarTMPK) as a potential target to the drug design against smallpox. We first built a homology model for VarTMPK and performed molecular docking studies on it in order to investigate the interactions with inhibitors of Vaccinia virus TMPK (VacTMPK). Subsequently, molecular dynamics (MD) simulations of these compounds inside VarTMPK and human TMPK (HssTMPK) were carried out in order to select the most promising and selective compounds as leads for the design of potential VarTMPK inhibitors. Results of the docking and MD simulations corroborated to each other, suggesting selectivity towards VarTMPK and, also, a good correlation with the experimental data.

Address: a Laboratory of Molecular Modeling Applied to Chemical and Biological Defense (LMACBD) , Military Institute of Engineering , Praça General Tibúrcio 80, Rio de Janeiro , 22290-270 , Brazil .

DOI: 10.1080/07391102.2013.830578